Balance Sheet - Neumora Therapeutics, Inc. (NMRA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 182.53 | 307.58 | 453.98 | 371.88 | 409.25 | 191.98 | 0.00 |
| Accounts receivable, net | 0.94 | 0.92 | 0.20 | 0.15 | |||
| Inventories | 0.05 | 0.13 | |||||
| Other current assets | 8.01 | 6.48 | 23.36 | 15.15 | 6.16 | 1.72 | |
| Total current assets | 190.54 | 314.06 | 478.28 | 387.96 | 415.60 | 193.84 | 0.00 |
| Total non-current assets | 0.51 | 2.92 | 17.92 | 38.28 | 13.69 | 4.11 | 0.00 |
| Total assets | 191.05 | 316.97 | 496.20 | 426.23 | 429.30 | 197.95 | 0.00 |
| Total current liabilities | 32.45 | 29.89 | 25.11 | 23.70 | 23.28 | 9.37 | 0.02 |
| Total non-current liabilities | 54.73 | 0.02 | 2.01 | 849.39 | 731.24 | 282.96 | 0.00 |
| Total liabilities | 87.18 | 29.91 | 27.12 | 873.08 | 754.52 | 292.33 | 0.02 |
| Total stockholders' equity | 103.87 | 287.06 | 469.08 | -446.85 | -325.22 | -94.38 | -0.02 |
| Common shares outstanding | 163 | 159 | 159 | 152 | 152 | 152 | 152 |
Show Quarterly Balance Sheet
Balance Sheet - Neumora Therapeutics, Inc. (NMRA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 147.07 | 182.53 | 171.53 | 217.59 | 249.35 | 307.58 | 341.31 | 371.64 | 422.72 | 453.98 | 509.57 | 324.20 | 345.55 | 371.88 | 0.00 | 327.51 | 349.62 | 409.25 | 439.15 | 0.00 | 0.00 | 191.98 |
| Accounts receivable, net | 1.63 | 0.91 | 0.94 | 0.67 | 0.59 | 0.79 | 0.92 | 0.92 | 0.59 | 0.27 | 0.20 | 0.27 | 0.15 | |||||||||
| Inventories | -0.67 | 0.05 | 0.05 | |||||||||||||||||||
| Other current assets | 6.36 | 8.01 | 5.56 | 5.32 | 5.51 | 6.48 | 7.30 | 25.05 | 19.16 | 23.36 | 16.17 | 11.82 | 13.63 | 15.15 | 13.53 | 12.29 | 13.03 | 6.16 | 3.67 | 1.72 | ||
| Total current assets | 153.43 | 190.54 | 177.08 | 222.91 | 254.87 | 314.06 | 348.61 | 398.32 | 442.79 | 478.28 | 525.74 | 336.61 | 359.96 | 387.96 | 387.96 | 340.39 | 362.92 | 415.60 | 443.08 | 193.84 | ||
| Total non-current assets | 0.44 | 0.51 | 0.75 | 0.92 | 1.88 | 2.92 | 3.93 | 6.15 | 7.43 | 17.92 | 19.01 | 23.34 | 32.13 | 38.28 | 23.19 | 19.91 | 13.69 | 8.89 | 4.11 | |||
| Total assets | 153.88 | 191.05 | 177.83 | 223.83 | 256.75 | 316.97 | 352.54 | 404.47 | 450.21 | 496.20 | 544.75 | 359.95 | 392.09 | 426.23 | 363.58 | 382.84 | 429.30 | 451.98 | 197.95 | |||
| Total current liabilities | 30.12 | 32.45 | 25.84 | 21.16 | 28.38 | 29.89 | 31.74 | 23.13 | 24.61 | 25.11 | 29.12 | 26.09 | 21.78 | 23.70 | 23.70 | 22.86 | 17.93 | 23.28 | 20.95 | 9.37 | ||
| Total non-current liabilities | 53.08 | 54.73 | 19.83 | 19.79 | 0.00 | 0.02 | 0.06 | 0.09 | 1.06 | 2.01 | 2.93 | 847.41 | 4.55 | 849.39 | 735.43 | 730.93 | 731.24 | 731.47 | 282.96 | |||
| Total liabilities | 83.20 | 87.18 | 45.67 | 40.95 | 28.38 | 29.91 | 31.80 | 23.21 | 25.67 | 27.12 | 32.06 | 873.49 | 26.33 | 873.08 | 758.29 | 748.85 | 754.52 | 752.42 | 292.33 | |||
| Total stockholders' equity | 70.68 | 103.87 | 132.16 | 182.88 | 228.36 | 287.06 | 320.74 | 381.26 | 424.54 | 469.08 | 512.69 | -513.54 | 365.77 | -446.85 | -394.71 | -366.02 | -325.22 | -300.45 | -94.38 | |||
| Common shares outstanding | 180 | 163 | 162 | 162 | 161 | 161 | 160 | 159 | 158 | 159 | 159 | 152 | 152 | 152 | 152 | 152 | 152 | 152 | 152 | 152 | 152 | 152 |